These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34093858)

  • 1. Magnetism-mediated targeting hyperthermia-immunotherapy in "cold" tumor with CSF1R inhibitor.
    Fang Y; He Y; Wu C; Zhang M; Gu Z; Zhang J; Liu E; Xu Q; Asrorov AM; Huang Y
    Theranostics; 2021; 11(14):6860-6872. PubMed ID: 34093858
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells.
    Pfirschke C; Zilionis R; Engblom C; Messemaker M; Zou AE; Rickelt S; Gort-Freitas NA; Lin Y; Bill R; Siwicki M; Gungabeesoon J; Sprachman MM; Marquard AN; Rodell CB; Cuccarese MF; Quintana J; Ahmed MS; Kohler RH; Savova V; Weissleder R; Klein AM; Pittet MJ
    Cancer Immunol Res; 2022 Jan; 10(1):40-55. PubMed ID: 34795032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.
    O'Brien SA; Orf J; Skrzypczynska KM; Tan H; Kim J; DeVoss J; Belmontes B; Egen JG
    Cancer Immunol Immunother; 2021 Aug; 70(8):2401-2410. PubMed ID: 33511454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of CD8
    Zhang Y; Gao X; Yan B; Wen N; Lee WSV; Liang XJ; Liu X
    ChemMedChem; 2022 Jan; 17(2):e202100656. PubMed ID: 34806311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis.
    Liu X; Zheng J; Sun W; Zhao X; Li Y; Gong N; Wang Y; Ma X; Zhang T; Zhao LY; Hou Y; Wu Z; Du Y; Fan H; Tian J; Liang XJ
    ACS Nano; 2019 Aug; 13(8):8811-8825. PubMed ID: 31328922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy.
    Lv Q; Yang H; Wang D; Zhou H; Wang J; Zhang Y; Wu D; Xie Y; Lv Y; Hu L; Wang J
    J Med Chem; 2024 Apr; 67(8):6854-6879. PubMed ID: 38593344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rh-CSF1 Attenuates Oxidative Stress and Neuronal Apoptosis via the CSF1R/PLCG2/PKA/UCP2 Signaling Pathway in a Rat Model of Neonatal HIE.
    Hu X; Li S; Doycheva DM; Huang L; Lenahan C; Liu R; Huang J; Gao L; Tang J; Zuo G; Zhang JH
    Oxid Med Cell Longev; 2020; 2020():6801587. PubMed ID: 33101590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12.
    Jiang X; Cao G; Gao G; Wang W; Zhao J; Gao C
    J Cell Physiol; 2021 Jan; 236(1):193-204. PubMed ID: 32495392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
    Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
    Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
    Fernandez MF; Qiao G; Tulla K; Prabhakar BS; Maker AV
    J Surg Res; 2021 Jul; 263():44-52. PubMed ID: 33631377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.
    Webb MW; Sun J; Sheard MA; Liu WY; Wu HW; Jackson JR; Malvar J; Sposto R; Daniel D; Seeger RC
    Int J Cancer; 2018 Sep; 143(6):1483-1493. PubMed ID: 29665011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
    Wang Y; Luan Z; Zhao C; Bai C; Yang K
    Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer.
    Lu X; Meng T
    Immunobiology; 2019 May; 224(3):355-361. PubMed ID: 30926154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
    Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
    Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R.
    Czako B; Marszalek JR; Burke JP; Mandal P; Leonard PG; Cross JB; Mseeh F; Jiang Y; Chang EQ; Suzuki E; Kovacs JJ; Feng N; Gera S; Harris AL; Liu Z; Mullinax RA; Pang J; Parker CA; Spencer ND; Yu SS; Wu Q; Tremblay MR; Mikule K; Wilcoxen K; Heffernan TP; Draetta GF; Jones P
    J Med Chem; 2020 Sep; 63(17):9888-9911. PubMed ID: 32787110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.